The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity
Sheila Miknyoczki, Bruce Ruggeri, Jennifer V. Grobelny, Ralph E. Parchment(SciTech Development (United States)), Robert L. Hudkins(State Street (United States)), Mark A. Ator, Hong Chang(Oxford Medical Diagnostics (United Kingdom)), Candace S. Worrell, Natalie McGann, James Deibold, Jean Husten, Allison L. Zulli, Sonya Pritchard
Cited by 112
Related Papers
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
|Proceedings of the National Academy of Sciences|2008|723
Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
|ACS Chemical Neuroscience|2011|436
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
|Scientific Reports|2016|239
Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a Derivatives
|Journal of Medicinal Chemistry|1997|120